A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

The Phase Ib/II trial assessed evorpacept plus zanidatamab in previously treated, metastatic HER2-expressing cancers.

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical ...

Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...

The study, co-led by The University of Queensland and the South Australian Health and Medical Research Institute (SAHMRI), in ...

Fred Hutch Cancer Center researchers are seeking better ways to prevent, detect and treat bladder cancer. We are also working to better understand the factors that affect each person’s risk for this ...

Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its ...

Legislation to fund pediatric cancer research passed unanimously out of an Iowa House subcommittee Thursday after lawmakers ...

The only man in his immediate family to be without a cancer diagnosis, one Lynch syndrome patient made the trip to ...